Shanghai, China

Lihua Xie

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Lihua Xie: Innovator in Pharmaceutical Chemistry

Introduction

Lihua Xie is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of kinase inhibitor compounds. His innovative work has led to the filing of multiple patents, showcasing his expertise and dedication to advancing medical science.

Latest Patents

Lihua Xie's latest patents include the invention of polymorphic forms of a kinase inhibitor compound, along with pharmaceutical compositions containing the same. The preparation method disclosed in these patents allows for the production of various crystalline forms of the compound with high purity, suitable for large-scale production. The crystalline forms exhibit good stability and maintain a purity decrease of less than 2% for their main ingredient. This advancement is crucial for ensuring the efficacy and safety of pharmaceutical products.

Career Highlights

Throughout his career, Lihua Xie has worked with notable companies such as Equinox Sciences, LLC and Betta Pharmaceuticals Co., Ltd. His experience in these organizations has further honed his skills in pharmaceutical research and development.

Collaborations

Lihua has collaborated with various professionals in the field, including Congxin Liang, who has contributed to his research endeavors.

Conclusion

Lihua Xie's innovative work in the pharmaceutical industry, particularly in the development of kinase inhibitor compounds, highlights his significant impact on medical science. His patents reflect a commitment to advancing drug development and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…